Gene Transfer of a Chimeric Trans-Activator Is Immunogenic and Results in Short-Lived Transgene Expression

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Human Gene Therapy

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/10430340260201707PMID 12228016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential of gene therapy for pediatric neurotransmitter diseases: Lessons from Parkinson's disease

  2003cited by this paper
• Regulated production of proteins from muscle using gene transfer: potential therapeutic applications

  2003cited by this paper
• Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletal muscle and heart.

  2002cited by this paper
• Efficient Gene Regulation by PPARγ and Thiazolidinediones in Skeletal Muscle and Heart

  2002cited by this paper
• A versatile framework for the design of ligand-dependent, transgene-specific transcription factors.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Elicitation of High-Frequency Cytotoxic T-Lymphocyte Responses against both Dominant and Subdominant Simian-Human Immunodeficiency Virus Epitopes by DNA Vaccination of Rhesus Monkeys

  2001cited by this paper
• Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse.

  2001cited by this paper
• Muscle-Specific Promoters May Be Necessary for Adeno-Associated Virus-Mediated Gene Transfer in the Treatment of Muscular Dystrophies

  2001cited by this paper
• Restricting Expression Prolongs Expression of Foreign Genes Introduced into Animals by Retroviruses

  2000cited by this paper
• Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

  2000cited by this paper
• High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle.

  2000cited by this paper
• Targeted expression of HTLV-I envelope proteins in muscle by DNA immunization of mice.

  2000cited by this paper
• Development of a preventive vaccine for Ebola virus infection in primates

  2000cited by this paper
• An improved anion-exchange HPLC method for the detection and purification of adenoviral particles

  2000cited by this paper
• Efficient lentiviral transduction of liver requires cell cycling in vivo

  2000cited by this paper
• Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity.

  2000influential reference
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

  2000cited by this paper
• Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses.

  1999cited by this paper
• Long-term regulated expression of growth hormone in mice after intramuscular gene transfer.

  1999cited by this paper
• High-efficiency gene transfer into skeletal muscle mediated by electric pulses.

  1999cited by this paper
• pCOR: a new design of plasmid vectors for nonviral gene therapy

  1999cited by this paper
• Measles Virus DNA Vaccination: Antibody Isotype Is Determined by the Method of Immunization and by the Nature of both the Antigen and the Coimmunized Antigen

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Recombinational construction in Escherichia coli of infectious adenoviral genomes.

  1997cited by this paper
• Liver-Directed Gene Transfer in Non-Human Primates

  1997cited by this paper
• Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential.

  1997cited by this paper
• Ligand-inducible and liver-specific target gene expression in transgenic mice

  1997cited by this paper
• Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

  1997cited by this paper
• An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge

  1997cited by this paper
• Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes

  1997cited by this paper
• Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization.

  1997cited by this paper
• A humanized system for pharmacologic control of gene expression

  1996cited by this paper
• Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells

  1996cited by this paper
• Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

  1996cited by this paper
• Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.

  1996cited by this paper
• Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

  1996cited by this paper
• Co-regulation of two gene activities by tetracycline via a bidirectional promoter.

  1995cited by this paper
• Tetracycline-reversible silencing of eukaryotic promoters

  1995cited by this paper
• Enumeration of lymphokine‐secreting cells as a quantitative measure for cellular immune responses in rhesus macaques

  1995influential reference
• Transcriptional activation by tetracyclines in mammalian cells.

  1995cited by this paper
• The mitogen‐induced generation of interferon‐gamma producing cells in cultures of rhesus monkey peripheral blood mononuclear cells is age‐dependent

  1994influential reference
• Establishment and characterization of Macaca fascicularis lymphoblastoid cell lines.

  1992cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Tetracyclines, molecular and clinical aspects.

  1992cited by this paper
• Direct Gene Transfer into Nonhuman Primate Myofibers In Vivo

  1992cited by this paper
• Secreted placental alkaline phosphatase as a eukaryotic reporter gene.

  1992cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper
• Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ‐interferon

  1990cited by this paper
• Expression of major histocompatibility complex class I antigens in rat muscle cultures: the possible developmental role in myogenesis.

  1989cited by this paper

• Machine-Guided Dual-Objective Protein Engineering for Deimmunization and Therapeutic Functions

  2025cites this paper
• ADARs: pleiotropy in function, versatility in application

  2025cites this paper
• Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cells

  2025cites this paper
• Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent “NoGlow” Mice

  2024cites this paper
• Control of mammalian gene expression by modulation of polyA signal cleavage at 5′ UTR

  2024cites this paper
• Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

  2023cites this paper
• Synthetic transcription factor engineering for cell and gene therapy.

  2023cites this paper
• pA regulator: a system for controlling mammalian gene expression via the modulation of polyA signal cleavage

  2023cites this paper
• AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System

  2022cites this paper
• Characterization of an immune-evading doxycycline-inducible lentiviral vector for gene therapy in the spinal cord.

  2022cites this paper
• Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy

  2022cites this paper
• Safety switches for adoptive cell therapy.

  2021cites this paper
• Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells

  2021cites this paper
• Externally-Controlled Systems for Immunotherapy: From Bench to Bedside

  2020cites this paper
• Safe and neuroprotective vectors for long-term traumatic brain injury gene therapy

  2019cites this paper
• A Microfluidic Platform to Investigate the Mechanism by which GDNF Overexpression in Schwann Cells Causes Neuronal Axon Entrapment

  2019cites this paper
• An update on gene therapy for lysosomal storage disorders

  2019cites this paper
• Timed GDNF gene therapy using an immune-evasive gene switch promotes long distance axon regeneration

  2019cites this paper
• A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy.

  2019cites this paper
• Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity

  2019cites this paper
• Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain

  2018cites this paper
• Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury

  2018cites this paper
• Adaptation of vectors and drug‐inducible systems for controlled expression of transgenes in the tumor microenvironment

  2017cites this paper
• Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer

  2017cites this paper
• CAR T-cell therapy: Balance of efficacy and safety

  2017cites this paper
• Regulierbare somatische ex vivo Gentherapie zur Behandlung neurodegenerativer Erkrankungen mittels PEDF

  2017cites this paper
• 1 General introduction. Nerve surgery and gene therapy: a neurobiological and clinical perspective

  2016cites this paper
• Methods to Understand Brain Connections and Neural Function Strategies for targeting primate neural circuits with viral vectors

  2016cites this paper
• Tet-On Systems For Doxycycline-inducible Gene Expression

  2016cites this paper
• Characterisation of a protease-dependent gene regulation system for gene therapy applications

  2015cites this paper
• Gene therapy and peripheral nerve repair: a perspective

  2015cites this paper
• Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes.

  2015cites this paper
• Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy

  2015cites this paper
• Functional Analysis of Drosophila HSP70 Promoter with Different HSE Numbers in Human Cells

  2014cites this paper
• Vaccines & Vaccine Technologies

  2014cites this paper
• Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve

  2014cites this paper
• Effects of APC De-Targeting and GAr Modification on the Duration of Luciferase Expression from Plasmid DNA Delivered to Skeletal Muscle

  2014cites this paper
• Mice with humanized liver endothelium

  2014influential citation
• Transgene Regulation Using the Tetracycline-Inducible TetR-KRAB System after AAV-Mediated Gene Transfer in Rodents and Nonhuman Primates

  2014cites this paper
• “Glowing Head” Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts

  2014cites this paper
• Adeno-associated Virus-mediated, Mifepristone-regulated Transgene Expression in the Brain

  2013cites this paper
• Mass Spectrometry Reveals Changes in MHC I Antigen Presentation After Lentivector Expression of a Gene Regulation System

  2013cites this paper
• A next step in adeno‐associated virus‐mediated gene therapy for neurological diseases: regulation and targeting

  2013cites this paper
• Targeted Lentiviral Vectors: Current Applications and Future Potential

  2013cites this paper
• Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease.

  2013cites this paper
• MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation

  2013cites this paper
• A mifepristone-regulated adeno-associated viral vector system for regulated neurotrophic factor expression in the central nervous system.

  2013cites this paper
• Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system

  2012cites this paper
• Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issues.

  2012cites this paper
• Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells

  2012cites this paper
• Nerve surgery and gene therapy: a neurobiological and clinical perspective

  2011cites this paper
• Optimization of lentiviral vectors generation for biomedical and clinical research purposes: contemporary trends in technology development and applications.

  2011cites this paper
• Skeletal muscle cells: from local inflammatory response to active immunity

  2011cites this paper
• Cell transplantation and gene therapy in Parkinson's disease.

  2011cites this paper
• A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator

  2010cites this paper
• Doxycycline regulated lentiviral vectors.

  2010cites this paper
• Separating Lentiviral Vector Injection and Induction of Gene Expression in Time, Does Not Prevent an Immune Response to rtTA in Rats

  2010cites this paper
• Lack of Humoral Immune Response to the Tetracycline (Tet) Activator in Rats Injected Intracranially with Tet-off rAAV Vectors

  2010cites this paper
• Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule

  2010cites this paper
• In vivo gene regulation using tetracycline-regulatable systems

  2009cites this paper
• A steroid-inducible promoter for the cornea

  2009cites this paper
• Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice.

  2009cites this paper
• Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study

  2009cites this paper
• A novel inducible tyrosine kinase receptor to regulate signal transduction and neurite outgrowth

  2009cites this paper
• Retrovirus vectors.

  2008cites this paper
• Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block.

  2008cites this paper
• Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.

  2008cites this paper
• How not to be seen: immune-evasion strategies in gene therapy

  2008cites this paper
• Deliberate Regulation of Therapeutic Transgenes

  2008cites this paper
• Lentiviral Vectors Mediate Nonimmunosuppressive Rapamycin Analog-Induced Production of Secreted Therapeutic Factors in the Brain: Regulation at the Level of Transcription and Exocytosis

  2008cites this paper
• Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?

  2008cites this paper
• Developing strategies for detection of gene doping

  2008influential citation
• Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.

  2008cites this paper
• Immune responses to gene product of inducible promoters.

  2007cites this paper
• Gene delivery by lentivirus vectors

  2007cites this paper
• Novel gene switches.

  2007cites this paper
• Helper‐dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy

  2007cites this paper
• Generation and characterization of tTS‐H4: a novel transcriptional repressor that is compatible with the reverse tetracycline‐controlled TET‐ON system

  2007cites this paper
• Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

  2007cites this paper
• Lentiviral vectors for regulated and liver directed gene therapy

  2007cites this paper
• Application des techniques de thérapie génique aux maladies ostéo-articulaires

  2007cites this paper
• Progress Toward A Nonviral Gene Therapy Protocol for The Treatment of Anemia

  2007cites this paper
• Application techniques de thérapie aux maladies ostéo-articulaires

  2007cites this paper
• Développement de vecteurs lentiviraux régulables pour le transfert de gène dans le système nerveux central

  2007cites this paper
• [Gene therapy for osteoarticular disorders].

  2007cites this paper
• Translational considerations for CNS gene therapy

  2007cites this paper
• Tetracycline Regulated Systems in Functional Oncogenomics

  2007cites this paper
• Les copolymères à blocs pour le transfert de gènes dans le muscle squelettique

  2006cites this paper
• Lentiviral vectors for use in the central nervous system.

  2006cites this paper
• Gene therapy for arthritis: what next?

  2006cites this paper
• Development of stealth transgenes for gene therapy : evaluation of cis-acting inhibitors of antigen presentation

  2006cites this paper
• Characterization of an immuno(cid:146)stealth(cid:146) derivative of the herpes simplex virus thymidine k inase gene Characterization of an Immuno(cid:146)stealth(cid:146) Derivative of the H erp es S imp lex V irus T hy mid ine inase g ene

  2006cites this paper
• Tetracycline Regulated Systems in Functional Oncogenomics

  2006cites this paper
• ENGINEERING PROTEIN MOLECULAR SWITCHES TO REGULATE GENE EXPRESSION WITH SMALL MOLECULES

  2006cites this paper
• Pharmacologic transgene control systems for gene therapy

  2006cites this paper
• Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?

  2006cites this paper
• Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector.

  2006cites this paper
• Characterization of an immuno ‘stealth’ derivative of the herpes simplex virus thymidine-kinase gene

  2006cites this paper
• Immune responses against tetracycline‐dependent transactivators affect long‐term expression of mouse erythropoietin delivered by a helper‐dependent adenoviral vector

  2005cites this paper
• Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation

  2005cites this paper